more>>
CDER Priority NDA/BLA Approval Rates for Applications Received FY 98 - 06 and Approved Within 36 Months 100 2001 2002 90 1998 80 2005 1999 2000 200 ... more>>
Executive Summary NDAs Reduce Business Development Risk Business Development is an equally exciting and risky endeavor. Protect your organization ... more>>
CDER Standard NDA/BLA Approval Rates for Applications Received FY 98 - 05 and Approved Within 36 Months 100 90 80 2002 1998 2003 2000 1999 70 Perc ... more>>
Guidance for Industry Topical Dermatological Drug Product NDAs and ANDAs ---In Vivo Bioavailability, Bioequivalence, In Vitro Release, and Associated ... more>>
Guidance for Industry Providing Regulatory Submissions in Electronic Format — Annual Reports for NDAs and ANDAs DRAFT GUIDANCE This guidance document ... more>>
Guidance for Industry Topical Dermatological Drug Product NDAs and ANDAs — In Vivo Bioavailability, Bioequivalence, In Vitro Release, and Associated S ... more>>
This is an example of an NDA. This document is useful in creating conducting a study on NDA. more>>
Non-disclosure agreements (also called NDAs or confidentiality agreements) have become increasingly important for businesses of all sizes, serving as ... more>>
A mutual non-disclosure agreement is like a confidentiality agreement, except that instead of being an agreement between a company and an employee it ... more>>